Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/refractory-postallogeneic-stem-cell-transplant-pure-red-cell-aplasia-qAPoUaPnrU
References (11)
-
M. Dimopoulos, R. Niesvizky, P. Moreau, D. Siegel, R. Hájek, M. Mateos, M. Cavo, Mei Huang, A. Zahlten-Kumeli, K. Weisel (2018)
Once Weekly Versus Twice Weekly Carfilzomib Dosing in Patients with Relapsed and Refractory Multiple Myeloma (A.R.R.O.W.): Efficacy and Safety Analyzed By Age GroupBlood
-
Matthew Sullivan, A. Danilov, F. Lansigan, N. Dunbar (2015)
Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchangeJournal of Clinical Apheresis, 30
-
N. Worel (2015)
ABO-Mismatched Allogeneic Hematopoietic Stem Cell TransplantationTransfusion Medicine and Hemotherapy, 43
-
C. Chapuy, R. Kaufman, E. Alyea, J. Connors (2018)
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation.The New England journal of medicine, 379 19
-
T. Plesner, J. Krejcik (2018)
Daratumumab for the Treatment of Multiple MyelomaFrontiers in Immunology, 9
-
R. Means (2016)
Pure red cell aplasia.Hematology. American Society of Hematology. Education Program, 2016 1
-
D. Siegel, T. Martin, A. Nooka, R. Harvey, R. Vij, R. Niesvizky, A. Badros, S. Jagannath, L. Mcculloch, K. Rajangam, S. Lonial (2013)
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studiesHaematologica, 98
-
(2014)
cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study -
M. Dimopoulos, H. Goldschmidt, R. Niesvizky, D. Joshua, W. Chng, A. Oriol, R. Orlowski, H. Ludwig, T. Facon, R. Hájek, K. Weisel, V. Hungria, L. Minuk, S. Feng, A. Zahlten-Kumeli, A. Kimball, P. Moreau (2017)
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial.The Lancet. Oncology, 18 10
-
R. Boccia, A. Bessudo, R. Agajanian, P. Conkling, W. Harb, Hui Yang, D. Pinchasik, A. Kimball, J. Berenson (2017)
A Multicenter, Open‐Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION‐2)Clinical Lymphoma, Myeloma & Leukemia, 17
-
F. Aung, B. Lichtiger, R. Bassett, Ping Liu, A. Alousi, Qaiser Bashier, S. Ciurea, M. Lima, C. Hosing, P. Kebriaei, Y. Nieto, B. Oran, S. Parmar, M. Qazilbash, N. Shah, I. Khouri, R. Champlin, U. Popat (2013)
Incidence and natural history of pure red cell aplasia in major ABO‐mismatched haematopoietic cell transplantationBritish Journal of Haematology, 160
- Publisher
- Wiley
- Copyright
- © 2019 Wiley Periodicals, Inc.
- ISSN
- 0361-8609
- eISSN
- 1096-8652
- DOI
- 10.1002/ajh.25515
- Publisher site
- See Article on Publisher Site
Abstract
Journal
American Journal of Hematology – Wiley
Published: Aug 1, 2019